Course overview
Dive into the world of metered-dose inhaler (MDI) technology with this interactive and insightful course designed to cover its past, present, and importantly the future, of MDIs. Whether you're new to the field or seeking a valuable refresher, this course offers a deep understanding of why MDIs have been and continue to be, a key delivery platform for the treatment of respiratory diseases, why and how MDIs work and the economic, regulatory and environmental pressures driving change in MDI technology.
You'll gain clarity on how these environmental, regulatory, and economic pressures are driving MDI development, manufacturing processes, intellectual property, equipment choices, and quality standards.
With expert-led sessions covering testing and analysis, manufacturing processes and equipment, fault investigation, regulatory expectations in the 2020s and beyond, you’ll leave with practical knowledge you can apply right away. Plus, benefit from exercises and workshops and dedicated time for discussions to tackle your specific challenges with a seasoned industry expert.
CPD Hours: 12
Course Content
- Day 1
- Metered dose inhalers - overview
- MDI technology
- MDI manufacture
- MDI testing
- Regulation of MDIs
- Developing an MDI
- MDIs and the environment
- The future of the MDI
- Extended Workshop / Case Studies
Speakers
David Howlett
In 2003 David established PharmaDelivery Solutions Ltd as a specialised consultancy service in the field of drug delivery combination products (especially respiratory) device technology. This has led to involvement in projects with focus in pulmonary, nasal and other delivery routes, with an international client base. Much of the activity of PharmaDelivery Solutions Ltd is focused in the area of development programme support, regulatory GAP analysis and generation of documentation supporting development and test programmes, together with data review and contingency evaluation.
David has over 35 years experience in the development, industrialization and approval of inhalation drug delivery systems, combination products and medical devices.
PharmaDelivery Solutions Ltd has provided input ranging from GAP analysis and comment to complete remedial implementation in areas including
• Design Control
• Risk Management
• Materials strategies
• Regulatory documentation
• Technical reviews and opinion
In addition to activities supporting commercial organizations, David has been involved in the following roles;
Honorary Teaching Fellow in the School of Pharmacy and Pharmaceutical Sciences at the University of Manchester and is author/ tutor for the Pharmaceutical Industry Advanced Training (PIAT) MSc module on Inhalation dosage forms.
A UK national expert representing the British Standards Institute on ISO TC84 developing new international standards for pulmonary and nasal delivery devices syringes and catheters.
David has also worked with the United Nations and various national governments to develop and establish transition strategies from the use of CFC in Metered Dose Inhalers and to secure appropriate budgets from the Multi-lateral fun for the implementation of the Montreal Protocol in emerging markets around the world.
